SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Ilya Sutskever rejected Meta’s bid for his $32B startup, so Zuckerberg is hiring his CEO instead

Iran targets Microsoft Be’er Sheva offices, damages residential complex

Weizmann Institute suffers over $500 million in damage from missile strike

"Increase your exposure to Israel. Long-term, that’s the right move"

Buzz

Most popular

Daily

Weekly

1

“Catastrophic loss”: Inside the destruction of Weizmann’s research labs

2

Vibe coding fever: Solo entrepreneur’s Base44 acquired by Wix for $80 million

3

Weizmann Institute suffers over $500 million in damage from missile strike

4

Ilya Sutskever rejected Meta’s bid for his $32B startup, so Zuckerberg is hiring his CEO instead

5

Combat-ready and camera-eyed: The X-Intra drone joins Israel’s arsenal

Nasdaq

20 stories about Nasdaq

קולין חואנג מייסד פינדואודואו Pinduoduo אופיר דור

The Chinese Giant That Turns Shopping into a Role-Playing Game

11.11.19|Ofir Dor

Pinduoduo’s collective buying-based business model succeeds where Groupon failed, making it a bright new star on the Chinese e-commerce scene and one of Nasdaq’s hottest tickets

Teva-Linked Biotech Company 89Bio Files for Nasdaq IPO

Israel and San Francisco-based 89Bio raised a $60 million series A in October 2018

משה מזרחי מייסד חברת הום סקינוביישנס

Medical Aesthetic Device Manufacturer InMode Raises $70 Million on Nasdaq IPO

11.08.19|Golan Hazani

InMode priced its shares at $14, the lower end of its previously suggested range, giving the company a pre-money valuation of $378 million

Medical Aesthetic Devices Manufacturer InMode Looking to Raise $75 Million on Nasdaq

In June, Calcalist reported that InMode is looking to list on Nasdaq according to a company valuation of $400 million to $500 million

SEC Sends Enforcement Action Notice to Interception Firm Ability

23.06.19|Tzally Greenberg

The notice is the result of an anti-fraud violation investigation that has been ongoing since 2017 and pertains to Ability's 2015 merger with shelf company Cambridge

Kornit Digital Prices Public Offering at $119 Million

16.06.19|Tzally Greenberg

The Nasdaq-listed printer manufacturer will issue 11% of its stock at $27.5 per share, slightly under its Friday closing price of $28.39

Kornit Digital Aims to Raise $130 Million in Public Offering

12.06.19|Micky Grunfeld

The Nasdaq-listed company has chosen Citigroup, Goldman Sachs, and Barclays as the bookrunners

מימין שי וינינגר ו דניאל שרייבר מייסדי Lemonade למונייד

Online Insurer Lemonade Heading for New York IPO

04.06.19|Golan Hazani

The SoftBank-backed company has hired JP Morgan as the underwriter and is looking to go public within six months, according to two people familiar with the matter

Medical Aesthetic Devices Manufacturer InMode Gearing Up for Nasdaq IPO

03.06.19|Golan Hazani

InMode develops devices that use radio-frequency energy technology, capable of penetrating subdermal fat

Medtech Company G Medical Innovation Files for Nasdaq IPO

The Israel-based, Sidney-listed company is aiming to raise $15 million under the ticker GMVD

בריינסוויי Brainsway

Brainsway Completes Nasdaq IPO With $27.5 Million

The Israeli company develops headsets that use magnetic stimulation to treat brain disorders

Brainsway to Start Trading on Nasdaq Wednesday

17.04.19|Lilach Baumer

The Israeli medical device company expects to raise $27.5 million in its initial public offering

נאסד"ק וול סטריט

InterCure Subsidiary Canndoc Files Confidential Nasdaq Prospectus

15.04.19|Tzally Greenberg

InterCure, chaired by former Israeli prime minister Ehud Barak, has previously announced its IPO intentions. Cannadoc is one of nine licensed cannabis growers in Israel

ועידת התחזיות 2019 בצלאל מכליס נשיא ו מנכ"ל אלביט

Elbit Intends to Raise $186 in Private Offering

09.04.19|Golan Hazani

The defense contractor announced it has obtained the commitment of several Israeli institutional investors to acquire 1.4 million shares at a price of $132 per share

נאסד"ק וול סטריט

Nasdaq-Listed Biopharma Company Chiasma Raises $34.5 Million in Public Offering

Chiasma develops octreotide capsules for the treatment of acromegaly, a rare, chronic disease typically caused by a benign tumor of the pituitary gland

הבורסה לניירות ערך רחוב אחוזת בית תל אביב

Email Protection Company Cyren to Delist from Tel Aviv Exchange on Wednesday

04.04.19|Lilach Baumer

Cyren was founded in Israel in 1991 as an email services provider and changed direction after its 1999 Nasdaq IPO

מונית של גט טקסי Gatt

Ahead of Potential IPO, Gett Changes Chief Financial Officer

31.03.19|Meir Orbach

Aliaksei Aneichyk, until recently a senior executive at Credit Suisse, will be stepping in following Tal Brener’s resignation

Cell Immunotherapy Company Enlivex Merges With Nasdaq-Listed Bioblast, Raises $5.3 Million

28.03.19|Lilach Baumer

The merged entity listed on Nasdaq under the ticker “ENLV”

הבורסה לניירות ערך רחוב אחוזת בית תל אביב

Anchiano Therapeutics Schedules TASE Delisting

14.03.19|Lilach Baumer

Based in Jerusalem and Cambridge, Massachusetts, clinical-stage Anchiano develops gene therapies for cancer, with a special focus on bladder cancer

יו" סטרטסיס והמנכ"ל בפועל אלחנן יגלום

U.S. Government Shutdown Tanked Fourth Quarter Sales, Says Stratasys

10.03.19|Hezi Sternlicht

Stratasys manufacturers 3D printers and production systems for several industries, including aerospace, automotive, healthcare, and consumer products

Previous Articles More Articles